Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure CancerProceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for the company's breakthrough cancer treatment, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy). TEL AVIV, Israel, September 5, 2018-- Alpha Tau Medical, developer of a breakthrough alpha radiation cancer therapy, announced today that it has secured $29 million in private financing.